← Leaderboards
Xu Chen
University Of California, San Francisco
$3,581,285
Attributed
$3,581,285
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,581,285 · 2
By mechanism
R01$3,581,285 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- David Antonetti$16,933,384
- Helen Kim$11,471,453
- Armin Reza Afshar$1,130,602
- Gregory P Victorino$594,000
- Joanne N. Engel$29,989,228
Others in their field
Other Rising Stars on “Mediating”
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Suma Babu · Massachusetts General Hospital$25,538,716
- Sabrina Paganoni · Massachusetts General Hospital$25,538,716
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
Research focus
MediatingMetastatic Neoplasm To The LiverImmune Checkpoint BlockadeMalignant NeoplasmsMelanomaExperimental StudyFeedbackGnaq GeneKnock-OutLiverClinical EfficacyBraf GeneCell ProliferationCombined Modality TherapyAutomobile DrivingCoupledCrispr/Cas TechnologyGenetic EngineeringInhibitorKnock-In MouseDiglyceridesKnockout MiceEffective TherapyMetastatic To
Grant awards (7)
Targeting Gq pathway in uveal melanoma$908,647
R01 · FY2025 · CA · contact PI
RasGRP3 and Protein Kinase D as therapeutic targets for Uveal Melanoma$454,865
R01 · FY2025 · CA · contact PI
RasGRP3 and Protein Kinase D as therapeutic targets for Uveal Melanoma$432,122
R01 · FY2024 · CA · contact PI
Targeting Gq pathway in uveal melanoma$431,571
R01 · FY2024 · CA · contact PI
RasGRP3 and Protein Kinase D as therapeutic targets for Uveal Melanoma$454,716
R01 · FY2023 · CA · contact PI
Targeting Gq pathway in uveal melanoma$445,160
R01 · FY2023 · CA · contact PI
Targeting Gq pathway in uveal melanoma$454,204
R01 · FY2022 · CA · contact PI